Dr. Steinberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1616Fax+1 319-356-3900
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2018 - 2020
- University of Iowa Hospitals and ClinicsResidency, Urology, 2012 - 2018
- Rush Medical College of Rush University Medical CenterClass of 2012
- University of Illinois at Urbana-ChampaignBS, Bioengineering, Highest Honors, 2004 - 2008
Certifications & Licensure
- IA State Medical License 2012 - 2025
- TX State Medical License 2018 - 2021
- American Board of Urology Urology
Awards, Honors, & Recognition
- 3rd Place Poster Society of Urologic Oncology (17th Annual Conference), 2016
- Most Outstanding Poster University of Iowa Health Sciences (Research Week), 2015
- College of Engineering Accenture Outstanding Junior Award Recipient 2007
Publications & Presentations
PubMed
- 13 citationsDesign and Validation of a Low-Cost, High-Fidelity Model for Urethrovesical Anastomosis in Radical Prostatectomy.Brett A. Johnson, Matthew D. Timberlake, Ryan L. Steinberg, Matthew Kosemund, Bradly Mueller
Journal of Endourology. 2019-04-09 - 93 citationsMulti-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer.Ryan L. Steinberg, Lewis Thomas, Nathan A. Brooks, Sarah L. Mott, Andrew Vitale
The Journal of Urology. 2020-05-01 - 6 citationsSequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non-Muscle-Invasive Bladder Cancer.Ian M McElree, Vignesh T Packiam, Ryan L Steinberg, Sarah L Mott, Paul T Gellhaus
The Journal of Urology. 2022-11-01
Journal Articles
- Magnetic-Assisted Robotic Surgery: Initial Case Series of Reduced-Port Robotic ProstatectomyJeffrey A Cadeddu, Brett A Johnson, Ryan L Steinberg, Journal of Robotic Surgery
- "Quadruple Immunotherapy of Bacillus Calmette-Guerin, Interferon, Interleukin-2 and Granulocyte Macrophage Colony Stimulating Factor as Salvage Therapy for Non-Muscle ...Steinberg RL, Velaer KN, Thomas LJ, O'Donnell MA, Nepple KG, Urologic Oncology, 1/8/2017
- "Bacillus Calmette-Guerin (BCG) Strain Does not Affect Recurrence-free Survival when used Intravesically with Interferon-alpha2b for Non-muscle Invasive Bladder Cancer"Steinberg RL, Brooks NA, Thomas LJ, Mott SL, O'Donnell MA, Urologic Oncology: Seminars and Original Investigations, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- 24 Hour Urine Utilization in Nephrolithiasis Treatment: Results from M-STONE (Multi-center collaboration to Study Treatment Outcomes in Nephrolithiasis Evaluation).Antonelli J, Bentley T, Best S, Nakada S, Tracy C, Steinberg R, Thomas L, Marien T, Miller N, Cohen A, Kolitz E, Li X, Huet B, Pearle M, Lotan Y, 2017 Annual Meeting of the American Urological Association Education and Research Inc, Boston, MA, 1/12/2017
- Quality of Life in Patients Treated with Bacillus Calmette-Guerin Plus Interferon.Steinberg RL, Brooks N, Thomas LJ, Mott SJ, O'Donnell MA, 91st Meeting of the North Central Section Meeting of the AUA, 1/1/2017
- Observed Increase in the Incidence of Testicular Cancer in Northern Iowa from 2010-2016.Steinberg RL, Mulholland TJ, Rier KR, Adams CE, 91st Meeting of the North Central Section Meeting of the AUA, 1/1/2017
- Join now to see all
Other
- "Do Ureteral Stent Extraction Strings Affect Quality of Life or Postoperative Complications Following Ureteroscopy for Urolithiasis: A Prospective Randomized Control T...Barnes KT, Steinberg RL, Bing MT, Tracy CR, BJUI Article of the Week (Video)
http://www.bjuinternational.com/videos/video-stent-extraction-strings-after-ureteroscopy/
1/16/2014
Press Mentions
- Inexpensive Combo-Chemotherapy Found to Be Better Tolerated Than BCG for Common Bladder CancerFebruary 28th, 2023
- Given the Lack of Standard BCG Treatments Worldwide, an Alternative Bladder Cancer Treatment Is EvolvingFebruary 28th, 2023
Professional Memberships
- Member
- Endourological SocietyMember
- Iowa Urological SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: